Folgen
Veronica Steri
Veronica Steri
Preclinical Therapeutics Core Manager, HDFCCC
Bestätigte E-Mail-Adresse bei ucsf.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
E Allen, A Jabouille, LB Rivera, I Lodewijckx, R Missiaen, V Steri, K Feyen, ...
Science translational medicine 9 (385), eaak9679, 2017
6332017
Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain
G Faure-André, P Vargas, MI Yuseff, M Heuzé, J Diaz, D Lankar, V Steri, ...
Science 322 (5908), 1705-1710, 2008
3252008
Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets
D Piccioli, S Tavarini, E Borgogni, V Steri, S Nuti, C Sammicheli, ...
Blood, The Journal of the American Society of Hematology 109 (12), 5371-5379, 2007
2702007
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies
K Lou, V Steri, AY Ge, YC Hwang, CH Yogodzinski, AR Shkedi, ALM Choi, ...
Science signaling 12 (583), eaaw9450, 2019
1392019
HER2 amplification in tumors activates PI3K/Akt signaling independent of HER3
A Ruiz-Saenz, C Dreyer, MR Campbell, V Steri, N Gulizia, MM Moasser
Cancer research 78 (13), 3645-3658, 2018
1062018
Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules
B He, A Jabouille, V Steri, A Johansson‐Percival, IP Michael, ...
The Journal of pathology 245 (2), 209-221, 2018
842018
Antagonizing integrin β3 increases immunosuppression in cancer
X Su, AK Esser, SR Amend, J Xiang, Y Xu, MH Ross, GC Fox, ...
Cancer research 76 (12), 3484-3495, 2016
742016
Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins
K Pance, JA Gramespacher, JR Byrnes, F Salangsang, JAC Serrano, ...
Nature biotechnology 41 (2), 273-281, 2023
542023
Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice
V Steri, TS Ellison, AM Gontarczyk, K Weilbaecher, JG Schneider, ...
Circulation research 114 (1), 79-91, 2014
542014
Redefining the role (s) of endothelial αvβ3-integrin in angiogenesis
SJ Atkinson, TS Ellison, V Steri, E Gould, SD Robinson
Biochemical Society transactions 42 (6), 1590-1595, 2014
522014
A covalent inhibitor of K-Ras (G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
Z Zhang, PJ Rohweder, C Ongpipattanakul, K Basu, MF Bohn, EJ Dugan, ...
Cancer Cell 40 (9), 1060-1069. e7, 2022
472022
Systematic identification of engineered methionines and oxaziridines for efficient, stable, and site-specific antibody bioconjugation
SK Elledge, HL Tran, AH Christian, V Steri, B Hann, FD Toste, CJ Chang, ...
Proceedings of the National Academy of Sciences 117 (11), 5733-5740, 2020
452020
Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
MA Nix, K Mandal, H Geng, N Paranjape, YHT Lin, JM Rivera, ...
Cancer discovery 11 (8), 2032-2049, 2021
412021
Transit-amplifying cells coordinate changes in intestinal epithelial cell-type composition
LE Sanman, IW Chen, JM Bieber, V Steri, C Trentesaux, B Hann, ...
Developmental cell 56 (3), 356-365. e9, 2021
382021
Suppression of β3-integrin in mice triggers a neuropilin-1-dependent change in focal adhesion remodelling that can be targeted to block pathological angiogenesis
TS Ellison, SJ Atkinson, V Steri, BM Kirkup, MEJ Preedy, RT Johnson, ...
Disease models & mechanisms 8 (9), 1105-1119, 2015
312015
The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
A Majumder, M Sandhu, D Banerji, V Steri, A Olshen, MM Moasser
Scientific reports 11 (1), 9091, 2021
242021
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells
JE Melnyk, V Steri, HG Nguyen, B Hann, FY Feng, KM Shokat
Bioorganic & medicinal chemistry 28 (20), 115712, 2020
212020
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers
SA Lim, J Zhou, AJ Martinko, YH Wang, EV Filippova, V Steri, D Wang, ...
The Journal of clinical investigation 132 (4), 2022
182022
Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma
ID Ferguson, YHT Lin, C Lam, H Shao, KM Tharp, M Hale, C Kasap, ...
Cell chemical biology 29 (8), 1288-1302. e7, 2022
132022
Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling
MR Campbell, A Ruiz-Saenz, Y Zhang, E Peterson, V Steri, J Oeffinger, ...
Cell reports 38 (5), 2022
102022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20